Pharmaceutical Institute Of India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 11-12-2024
- Paid Up Capital ₹ 4.31 M
as on 11-12-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -14.73%
(FY 2023)
- Profit -27.87%
(FY 2023)
- Ebitda 18.02%
(FY 2023)
- Net Worth 21.41%
(FY 2023)
- Total Assets 4.53%
(FY 2023)
About Pharmaceutical Institute Of India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.31 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Kyal and Vijay Kyal serve as directors at the Company.
- CIN/LLPIN
U51397OR2009PTC011331
- Company No.
011331
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pharmaceutical Institute Of India Private Limited offer?
Pharmaceutical Institute Of India Private Limited offers a wide range of products and services, including Sensors & Transducers, Pressure Sensor, Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Bath Soaps, Common Disease Medicines, Ear Drops, Psoriasis Ointment, Hydroquinone Cream, Ayurvedic Health Tonic.
Who are the key members and board of directors at Pharmaceutical Institute Of India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Kyal  | Director | 18-Nov-2009 | Current |
| Ashish Kyal | Director | 18-Nov-2009 | Current |
Financial Performance of Pharmaceutical Institute Of India.
Pharmaceutical Institute Of India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.73% decrease. The company also saw a substantial fall in profitability, with a 27.87% decrease in profit. The company's net worth Soared by an impressive increase of 21.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaceutical Institute Of India?
Unlock access to Pharmaceutical Institute Of India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmaceutical Institute Of India?
Pharmaceutical Institute Of India has a workforce of 0 employees as of May 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaceutical Institute Of India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaceutical Institute Of India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
